Deliver pure precision with CLIPP™

We’ve perfected our manufacturing processes so we can deliver our VMS and OTC customers consistent, high-quality products with CLIPP, our Closed Loop Integrated Precision Process. Explore our site to learn more about how we promise to deliver products manufactured with pure precision.

Pure precision, from source to seal

A trusted contract manufacturer for VMS and OTC pharmaceutical brands, Delavau has invested in bringing continuous manufacturing capabilities to our facility in Philadelphia, Pennsylvania.

Learn more

CLIPP™, our continuous manufacturing process:

delivers increased uniformity in chemical and physical properties of the granulation
allows for greater content uniformity and particle size consistency
maintains the consistency of granule size and shape, thereby ensuring better compression
continuously monitors Critical Process Parameters (CPP) to ensure that the Critical Quality Attributes (CQA) are constantly met
delivers uniform tablets with pure precision

Learn more

With continuous manufacturing capabilities, Delavau offers the highest quality products on the market for the best value.

From Concept to Completion

Delavau Pharmaceutical Partners combines our expertise, innovation, and capability to take VMS and OTC products from concept to packaged good with exact precision.

The Latest

Delavau Pharmaceutical Partners Welcomes Greg Sherman as VP of Operations

Delavau Pharmaceutical Partners offers industry-leading quality VMS and OTC products and service to our partners. As part of that mission, we are proud to announce that Greg Sherman has joined our Leadership Team as Vice President of Operations. “Greg brings to the Delavau team nearly 20 years of experience in the pharmaceutical and food industries,” Delavau President and CEO John Burrows said. “His passion and drive are already positively impacting our organization and operations, and we’re excited to see that translate to the contract manufacturing experience we deliver to our customers.” Greg comes to Delavau Pharmaceutical Partners with nearly...

WHITE PAPER: Improving Quality with Continuous Manufacturing

Continuous manufacturing is widely considered the future of the tablet manufacturing industry, and Delavau Pharmaceutical Partners is proud to offer large scale continuous manufacturing through CLIPP™, our Closed Loop Integrated Precision Process. Download our white paper below to learn more about this technology. Improving Quality with Continuous Manufacturing Please fill out the form below to receive a link to download this white paper. Name First Last Company Company Email Email Phone Phone

Curt Pagano Joins Delavau Pharmaceutical Partners as VP of Quality and Regulatory

PHILADELPHIA, PENNSYLVANIA – July 18, 2016 – For more than 150 years, Delavau has upheld the highest quality standards in servicing over-the-counter (OTC) and vitamin-mineral-supplement (VMS) brands. To further its commitment to quality and excellence, Delavau Pharmaceutical Partners has welcomed industry veteran Curt Pagano to its team as the Vice President of Quality and Regulatory. “We provide our customers everything from product development to finished goods, so maintaining high quality standards is imperative,” said John Burrows, Delavau Pharmaceutical Partners President and CEO. “Curt’s extensive knowledge and experience in the pharmaceutical space will be a great asset to our business...

Delavau Announces Pharmaceutical Business Name Change

PHILADELPHIA, PENNSYLVANIA – April 28, 2016 – For over 150 years, Delavau has served as a partner to leading over-the-counter (OTC) and vitamin-mineral-supplement (VMS) brands offering full turn-key contract manufacturing services. A reflection of its investment in capability and partnership, the contract manufacturer has changed its name to “Delavau Pharmaceutical Partners,” and is unveiling its new identity at the Ingredient Marketplace in Orlando. “For many of our customers, we’re an extension of their operations—we add to their capacity from product development to finished good. The evolution of our identity reflects this partnership,” said John Burrows, Delavau Pharmaceutical Partners’ President...